Incyte (INCY) Misses Q4 EPS by 76c
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $126.75 -0.98%
EPS Growth %: -225.2%
Financial Fact:
Income (loss) from operations: 22.29M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -225.2%
Financial Fact:
Income (loss) from operations: 22.29M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q4 EPS of $0.10, $0.76 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $862.85 million versus the consensus estimate of $815.3 million.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- UBS Downgrades Lai Yih Footwear Co Ltd (6890:TT) to Neutral
- JPMorgan Upgrades Yangzijiang Shipbuilding (YZJSGD:SP) (YSHLF) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
